Centrica's Valuation and Earnings Expectations Shift Amid Analyst Divergence
March 29, 2026, 3:48 AM EDT. Centrica's central fair value estimate has risen to £2.16 per share, reflecting updated analyst sentiment. Major banks like Citi, Goldman Sachs, and RBC Capital have increased price targets to between £2.18 and £2.32, backing the current valuation driven by factors such as the UK government's low carbon push and elevated gas prices. JPMorgan and RBC hold bullish ratings, while Morgan Stanley, Jefferies, and Kepler Cheuvreux adopt a more cautious stance due to limited near-term catalysts and a strong prior share price surge. Collaborations, notably with Ceres Power Holdings on low-carbon power solutions, add a strategic dimension to Centrica's growth narrative. Investors face risks related to fundamentals against recent price recoveries, highlighting careful monitoring ahead.
How to identify and avoid fake vapes amid £39m illegal UK market
March 29, 2026, 3:30 AM EDT.Illegal vapes worth £39 million have been seized across the UK over three years, with about 5 million devices confiscated. Fake products often lack safety features, raising fire and health risks. The UK Vaping Industry Association urges consumers to watch for missing UK distributor addresses, poor-quality packaging, and foreign language labels. Illegal devices may also have banned ingredients or excessive nicotine levels. Buyers should verify brand registration with the Medicines and Healthcare products Regulatory Agency and report suspicious sellers to UKVIA or Trading Standards. Vigilance is vital to avoid potentially hazardous counterfeit vape products.
FTSE 100 stocks Legal & General, Standard Life, M&G offer strong dividend yields amid market volatility
March 29, 2026, 3:29 AM EDT. The recent drop in the FTSE 100 index has pushed up dividend yields on select stocks, benefiting income-focused investors. Legal & General (LSE:LGEN) leads with a 9% yield, backed by a 6% profit rise in 2025 and steady asset growth despite a drop in Solvency II ratio. Standard Life (LSE:SDLF), yielding 8.3%, anticipates a 16.4% profit increase in 2026 and expects dividends to rise 9% by 2028, though it faces risks from UK economic pressures. M&G (LSE:MNG) delivered strong inflows and a 2% dividend hike in 2025 with a 7.4% yield, while improving its financial health. Combined investment of £15,000 in these three stocks could generate around £1,230 annually, but dividends remain subject to market and operational risks.
Keller Group plc (LON:KLR) Shows Potential as Undervalued Stock with Growth Prospects
March 29, 2026, 3:28 AM EDT. Keller Group plc's shares have gained 17% recently but remain below peak levels, suggesting room for growth. The stock trades under its estimated intrinsic value of £26.76, indicating potential undervaluation. Despite share price volatility, driven by a high beta, analysts forecast double-digit earnings growth in coming years. This growth outlook supports robust cash flows and potential share price appreciation. Investors might see this as an opportunity to buy or increase holdings before the market fully prices in future gains. However, risks remain, including leverage and management quality, which investors should assess carefully before committing capital.
Potato supply costs surge 40% amid Middle East conflict impacting global fertilizer routes
March 29, 2026, 3:17 AM EDT. The cost to supply potatoes has risen by up to 40% due to disruptions from the Middle East conflict, notably Iran's blockade of the Strait of Hormuz, a vital passage for a third of the world's fertilizers, natural gas, and crude oil. Farmers like Paul Brown in Staffordshire warn of increased input costs for fuel and fertilizer, raising concerns over crop yields and potential price hikes in stores. The National Farmers Union highlights possible price rises for cucumbers, tomatoes, and milk in coming months. With inflation pressures, many farmers face tighter margins and must decide whether to reduce fertilizer use, risking lower harvests. The UK government monitors the situation amid growing food inflation concerns.
Equinox Gold Shares Rise 6.2% After FTSE All-World Index Inclusion
March 29, 2026, 2:42 AM EDT. Equinox Gold Corp (TSX:EQX) surged 6.2% following its addition to the FTSE All-World Index on March 21, 2026. The index inclusion boosts the miner's visibility among institutional and index-tracking investors, potentially expanding its shareholder base and improving liquidity. Despite this, operational challenges remain, including grade stabilization at Greenstone and community issues at Los Filos. The company also announced a new capital return plan featuring a US$0.015 quarterly dividend and a share buyback of up to 5%, signaling management's confidence amid ongoing risks. Analysts project Equinox Gold could achieve $4.3 billion in revenue and $1.4 billion in earnings by 2028, implying a 54% upside from current prices. However, varied analyst views and unresolved community agreements suggest investors should weigh risks carefully.
ASX Shares Spotlight: HUB24 and Rio Tinto Performance and Valuation
March 29, 2026, 2:10 AM EDT. The Hub24 Ltd (ASX:HUB) share price has dropped 15.3% in 2025 amid strong revenue growth and a high price-to-sales ratio of 20.23x, above its 5-year average. HUB24 dominates wealth management software with platforms for financial advisers, superfunds, and accountants, winning key industry awards for service quality. Meanwhile, Rio Tinto Ltd (ASX:RIO), a global mining giant, trades 52.1% above its 52-week lows with a current dividend yield of 4.24%, below its 5-year average of 6.80%. Rio Tinto's portfolio spans aluminium, copper, diamonds, energy minerals, and iron ore. Investors use different valuation metrics for HUB's growth potential and RIO's dividend stability, highlighting varied approaches in the ASX market.
6 Key Metrics to Assess A2 Milk Company (A2M) Shares in 2025
March 29, 2026, 2:08 AM EDT. The A2 Milk Company (ASX:A2M) share price has risen 2.83% this year. Key financial indicators reveal a solid growth story: annual revenue stood at $1.67 billion with an 11.6% compound annual growth rate over three years. The firm's gross margin, a measure of core profitability, was 45.8%. Net profit hit $168 million last year, up from $81 million three years ago, reflecting a 27.6% CAGR. Financial health is strong with net debt at negative $903 million, signaling more cash than debt, and a low debt-to-equity ratio of 5.3%. Return on equity reached 12.8%, indicating efficient use of shareholder funds. These figures suggest A2M may continue on an upward trajectory in 2025, making it a stock to watch for investors interested in the dairy sector.
26-Year-Old Australian Woman Embraces Voluntary Assisted Dying Amid Chronic Illness
March 29, 2026, 12:16 AM EDT. Annaliese Holland, 26, from Adelaide, is approved for voluntary assisted dying (VAD) in South Australia due to a rare, incurable autoimmune illness. VAD allows eligible adults with terminal conditions to request medical assistance to end their life within 6 to 12 months. Despite the grim prognosis, Holland views the decision as empowering and aims to foster open dialogue about end-of-life care for young Australians. Diagnosed with Autoimmune Autonomic Ganglionopathy, she endures severe pain and debilitating symptoms daily. Holland has kept her chosen date private to protect her family, advocating for public awareness and support surrounding mortality and terminal illness.
